Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

stendhal panama, s.a - gemigliptina (tartrato sesquihidratado) - gemigliptina (tartrato sesquihidratado)....50.00 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

stendhal panamÁ s.a. - fimasartan potÁsico (trihidratado) - fimasartan potÁsico (trihidratado)....60.00 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

stendhal panamÁ s.a. - netupitant - netupitant....300 mg (3 tabletas de 100mg) / palonosetron (clorhidrato)....0.5 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

aa-med pty ltd - 61288 - home seizure monitoring system - the embrace is a wearable device, worn on the wrist of a child or adult, for use in home or in professional healthcare environments. it senses electro dermal activity and motion data in order to detect patterns that may indicate a possible convulsive seizure in patients with epilepsy or at risk of having epilepsy. when a seizure event is detected, it sends a command to a paired wireless device that is programmed to initiate an alert (or send an alarm) to a designated caregiver. it is optimized to detect seizures involving electro dermal activity and motion patterns with a duration of at least 20 seconds.these characteristics are generally associated with tonic-clonic seizures. it doesn?t detect every single generalized tonic-clonic seizure. it is not meant as substitute to seizure monitoring practices, but rather to serve as a supplement in expediting first-response time. it cannot detect complex partial seizures, absence seizures and non-convulsive seizures.

United States - English - NLM (National Library of Medicine)

mist pharmaceuticals, llc - avanafil (unii: dr5s136ivo) (avanafil - unii:dr5s136ivo) - avanafil 50 mg - stendra is a phosphodiesterase 5 (pde5) inhibitor indicated for the treatment of erectile dysfunction. administration of stendra with any form of organic nitrates, either regularly and/or intermittently, is contraindicated. consistent with its known effects on the nitric oxide/cyclic guanosine monophosphate (cgmp) pathway, stendra has been shown to potentiate the hypotensive effects of nitrates. in a patient who has taken stendra, where nitrate administration is deemed medically necessary in a life-threatening situation, at least 12 hours should elapse after the last dose of stendra before nitrate administration is considered. in such circumstances, nitrates should only be administered under close medical supervision with appropriate hemodynamic monitoring [see contraindications (4.1) , dosage and administration (2.3) , and clinical pharmacology (12.2) ] . stendra is contraindicated in patients with a known hypersensitivity to any component of the tablet. hypersensitivity reactions have been reported, incl

United States - English - NLM (National Library of Medicine)

metuchen pharmaceuticals, llc - avanafil (unii: dr5s136ivo) (avanafil - unii:dr5s136ivo) - stendra is a phosphodiesterase 5 (pde5) inhibitor indicated for the treatment of erectile dysfunction in adult males. administration of stendra with any form of organic nitrates, either regularly and/or intermittently, is contraindicated. consistent with its known effects on the nitric oxide/cyclic guanosine monophosphate (cgmp) pathway, stendra has been shown to potentiate the hypotensive effects of nitrates. in a patient who has taken stendra, where nitrate administration is deemed medically necessary in a life-threatening situation, at least 12 hours should elapse after the last dose of stendra before nitrate administration is considered. in such circumstances, nitrates should only be administered under close medical supervision with appropriate hemodynamic monitoring [see contraindications (4.1) , dosage and administration (2.3) , and clinical pharmacology (12.2) ] . stendra is contraindicated in patients with a known hypersensitivity to any component of the tablet. hypersensitivity reactions have been

United States - English - NLM (National Library of Medicine)

vivus llc - avanafil (unii: dr5s136ivo) (avanafil - unii:dr5s136ivo) - stendra is a phosphodiesterase 5 (pde5) inhibitor indicated for the treatment of erectile dysfunction. administration of stendra with any form of organic nitrates, either regularly and/or intermittently, is contraindicated. consistent with its known effects on the nitric oxide/cyclic guanosine monophosphate (cgmp) pathway, stendra has been shown to potentiate the hypotensive effects of nitrates. in a patient who has taken stendra, where nitrate administration is deemed medically necessary in a life-threatening situation, at least 12 hours should elapse after the last dose of stendra before nitrate administration is considered. in such circumstances, nitrates should only be administered under close medical supervision with appropriate hemodynamic monitoring [see contraindications (4.1), dosage and administration (2.3), and clinical pharmacology (12.2)] . stendra is contraindicated in patients with a known hypersensitivity to an

Australia - English - Department of Health (Therapeutic Goods Administration)

becton dickinson pty ltd - 43324 - fluid transfer set, general-purpose - a series of devices to transfer several types of medical fluids (e.g., drugs, vaccines, blood, and solutions) between a first container(s) [e.g., a vial(s)] and a second container [e.g., an intravenous (iv) bag]. it is available in a variety of configurations and typically includes connector, spike, tubing and caps. this is a single-use device

Australia - English - Department of Health (Therapeutic Goods Administration)

becton dickinson pty ltd - 35833 - electric infusion pump administration set - a collection of sterile devices (e.g., plastic tubing, check valve, roller clamp, y-site connector, luer, needle/catheter) intended to be used in combination with an electrically-powered infusion pump for the intravenous (iv), subcutaneous, intramuscular, or epidural administration of medication.

Australia - English - Department of Health (Therapeutic Goods Administration)

becton dickinson pty ltd - 32172 - infusion stopcock - this device is for use in intravascular or arterial lines to regulate fluid delivery to a patient's vascular system.